A 24-year-old male patient who had a cardiac resynchronization therapy device (CRT-D) implanted 2 years prior was admitted to our clinic with bilateral pretibial edema and abdominal ascites. Transthoracic echocardiography showed severe decreased left ventricular systolic function with an ejection fraction of 20% and mild-to-moderate mitral regurgitation. In addition, in the transthoracic echocardiography modified apical 4-chamber view, the coronary sinus (CS) lead of CRT-D showed excessive movement and it was acrossed the tricuspid inflow, and severe tricuspid regurgitation but without obstruction of the tricuspid valve closing was observed ([Fig. 1a](#F1){ref-type="fig"} and 1b, [Video 1](#SD1){ref-type="supplementary-material"} and [2](#SD2){ref-type="supplementary-material"}). On modified parasternal short axis and 3-D image from the apical 4 chamber view, excessive movement of the CS lead was displayed ([Fig. 1c](#F1){ref-type="fig"} and [1d](#F1){ref-type="fig"}, [Video 3](#SD3){ref-type="supplementary-material"} and [4](#SD4){ref-type="supplementary-material"}). Excessive movement of the lead toward the tricuspid inflow was seen during diastole, and tricuspid regurgitation was seen during sistole. Therefore, severe tricuspid regurgitation mechanism was not be caused by CS lead, and the patient had been followed up by medical treatment.

![(a) Transthoracic echocardiography modified apical 4 chamber view shows excessive movement of the CS lead of CRT-D (arrow). (b) Transthoracic echocardiography apical 4 chamber view shows severe tricuspid regurgitation (arrow). (c) Transthoracic echocardiography modified parasternal short axis view shows excessive movement of the CS lead of CRT-D (arrow). (d) Transthoracic echocardiography 3-D image from the apical 4 chamber view shows excessive movement of the CS lead of CRT-D (arrow)](AJC-19-E5-g001){#F1}
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Tricuspid regurgitation in patients with permanent pacemakers may not be exclusively caused by the endocardial lead as pre-existing abnormalities, such as tricuspid valve annular dilatation or pulmonary hypertension, may be present. The mechanism of tricuspid regugirtation plays an important role in the choice of treatment. If tricuspid regurgitation caused by the endocardial lead is managed by surgery, medical treatment is needed for other reasons. Defining the precise anatomical relationship between the tricuspid valve and the pacemaker lead is important for understanding the underlying tricuspid regurgitation mechanism.
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